Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.27
Delayed Data
As of Sep 28
 +0.01 / +0.44%
Today’s Change
1.84
Today|||52-Week Range
5.30
-53.10%
Year-to-Date
GW Pharma Attains 52-Week High on Positive Epidiolex Data
Sep 27 / Zacks.com - Paid Partner Content
Amgen (AMGN) Parsabiv Gets Positive CHMP Opinion in EU
Sep 19 / Zacks.com - Paid Partner Content
Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps
Sep 26 / Zacks.com - Paid Partner Content
Curis (CRIS) Shows Strength: Stock Adds 6.9% in Session
Sep 19 / Zacks.com - Paid Partner Content
Chiasma (CHMA) Shows Strength: Stock Moves 5.9% Higher
Sep 26 / Zacks.com - Paid Partner Content
Novavax Tanks, RSV F Vaccine Disappoints in Two Studies
Sep 16 / Zacks.com - Paid Partner Content
Teva Reports Positive Phase III Tardive Dyskinesia Data
Sep 23 / Zacks.com - Paid Partner Content
bluebird bio (BLUE) in Focus: Stock Moves 11.4% Higher
Sep 16 / Zacks.com - Paid Partner Content
Amgen (AMGN) Repatha Meets Endpoints in Phase III Study
Sep 21 / Zacks.com - Paid Partner Content
Spectrum (SPPI) Down, Qapzola Fails to Impress FDA Panel
Sep 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD ...
Sep 21 / Zacks.com - Paid Partner Content
Sarepta Shares Soar on News of Key Drug Critic FDA Exit
Sep 15 / Zacks.com - Paid Partner Content
Johnson & Johnson's Smart (Yet Surprising) Acquisition
Sep 20 / MotleyFool.com - Paid Partner Content
FDA Panel Suggests Removing Warning from Pfizer's Chantix
Sep 15 / Zacks.com - Paid Partner Content
AveXis (AVXS) Shows Strength: Stock Adds 6.3% in Session
Sep 20 / Zacks.com - Paid Partner Content
Glaxo (GSK) Publishes Phase III Data on Shingles Vaccine
Sep 15 / Zacks.com - Paid Partner Content
Celgene Presents Efficacy & Safety Phase II Ozanimod Data
Sep 20 / Zacks.com - Paid Partner Content
BeiGene (BGNE) Catches Eye: Stock Adds 6% in Session
Sep 15 / Zacks.com - Paid Partner Content
Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing
Sep 20 / Zacks.com - Paid Partner Content